Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

About: Tesmilifene

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Tesmilifene (INN; developmental code names YMB-1002, BMS-217380-01), also known as N,N-diethyl-2-(4-phenylmethyl)ethanamine (DPPE), is a small-molecule antineoplastic drug and chemopotentiator that was under development by YM BioSciences for the treatment of breast cancer in the 2000s but was never marketed. It reached phase III clinical trials for advanced/metastatic breast cancer before development was discontinued.

Property Value
dbo:abstract
  • Tesmilifene (INN; developmental code names YMB-1002, BMS-217380-01), also known as N,N-diethyl-2-(4-phenylmethyl)ethanamine (DPPE), is a small-molecule antineoplastic drug and chemopotentiator that was under development by YM BioSciences for the treatment of breast cancer in the 2000s but was never marketed. It reached phase III clinical trials for advanced/metastatic breast cancer before development was discontinued. Tesmilifene is a diphenylmethane derivative that is structurally related to the triphenylethylene derivative tamoxifen but lacks the stilbene bridge and third phenyl ring necessary for binding to the estrogen receptor (ER), and as such, it is not a selective estrogen receptor modulator (SERM). In addition to tamoxifen, tesmilifene is structurally related to diphenylmethane antihistamines like diphenhydramine and hydroxyzine, but is much weaker than these agents in assays of anti-H1 receptor activity, and hence, neither acts as an antihistamine. Tamoxifen is known to bind not only to the ER but also to non-ER so-called "antiestrogen binding sites" (AEBS) that are present in cell microsomes as opposed to the cell nucleus. Tesmilifene was developed as a selective ligand of the AEBS without ER affinity to investigate these sites and their role in the antineoplastic activity of tamoxifen. Histamine has been found to be a ligand of the AEBS, and it has been determined that the AEBS represent the substrate binding site of certain microsomal cytochrome P450 enzymes including CYP3A4, CYP2D6, and CYP1A1. Tesmilifene binds to and displaces histamine from these sites equipotently to tamoxifen and more strongly than conventional antihistamines, and this action has been found to correlate with the cytotoxic effects of tesmilifene in breast cancer cells in vitro. Moreover, in spite of its lack of affinity for the ER, tesmilifene antagonizes the uterotrophic effects of exogenous estrogen in vivo. (en)
dbo:casNumber
  • 92981-78-7 (hydrochloride)
  • 98774-23-3
dbo:chEBI
  • 93414
dbo:chEMBL
  • 26424
dbo:fdaUniiCode
  • I43T3ID6G2
dbo:pubchem
  • 108092
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 53753696 (xsd:integer)
dbo:wikiPageLength
  • 5693 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1072756645 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 19 (xsd:integer)
dbp:casNumber
  • 98774 (xsd:integer)
dbp:casSupplemental
  • 92981 (xsd:integer)
dbp:chebi
  • 93414 (xsd:integer)
dbp:chembl
  • 26424 (xsd:integer)
dbp:chemspiderid
  • 97190 (xsd:integer)
dbp:h
  • 25 (xsd:integer)
dbp:iupacName
  • 2 (xsd:integer)
dbp:n
  • 1 (xsd:integer)
dbp:o
  • 1 (xsd:integer)
dbp:pubchem
  • 108092 (xsd:integer)
dbp:smiles
  • CCNCCOC1=CC=CCC2=CC=CC=C2 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • NFIXBCVWIPOYCD-UHFFFAOYSA-N (en)
dbp:synonyms
  • BMS-217380-01; YMB-1002; DPPE (en)
dbp:unii
  • I43T3ID6G2 (en)
dbp:width
  • 250 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Tesmilifene (INN; developmental code names YMB-1002, BMS-217380-01), also known as N,N-diethyl-2-(4-phenylmethyl)ethanamine (DPPE), is a small-molecule antineoplastic drug and chemopotentiator that was under development by YM BioSciences for the treatment of breast cancer in the 2000s but was never marketed. It reached phase III clinical trials for advanced/metastatic breast cancer before development was discontinued. (en)
rdfs:label
  • Tesmilifene (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License